Pulished Date August, 2019
ID: 54
Share on
Share on

Therapeutic Vaccines Market Analysis - By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) & By Region - Global Industry Analysis on Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 54
Pages: 177

Therapeutic Vaccines Market Size & Growth (2019 - 2024)

The Global Therapeutic Vaccines Market is estimated at USD 2700.58 Million in 2019 and is poised to reach USD 11494.48 Million by 2024 with a CAGR of 33.6%. Currently, in the pipeline, several approaches are being developed in order to boost the immune response to various infectious and cancerous cells.

The vaccine Market is different from any other product market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. The vaccine market is rather concentrated on both the supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features that increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from the government for vaccine development, rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth.

However, massive capital expenditures and stringent regulatory policies, high costs associated with treatment are few factors inhibiting the growth of the market.

This research report on Global Therapeutic Vaccines Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Therapeutic Vaccines Market - By Disease Type

  • Autoimmune Disease Vaccines      
  • Cancer Vaccines   
    • Multikine
    • PR1 Peptide
    • TroVax
    • CYT004-MelQbG10
  • Neurological Disease Vaccines        
    • ACC- 001
    • CAD 106
    • Parkinson's Vaccine
    • Alzheimer's Vaccine
  • Infectious Disease Vaccines             
    • Hepatitis C Vaccines
    • HIV/AIDS Vaccines
    • Other Infectious Disease Vaccines

Based on the disease type, autoimmune disease vaccines is holding dominant shares of the market. Increasing prevalence for the manufacturing of various vaccines for different diseases to promote effective results is primarily accelerating the demand for the market. People's interest in innovative developments with the latest technologies is greatly influencing the demand of the market. The rise in the demand for targeted diseases is also surging the growth of the market. Therapeutic vaccines are highly effective in treating the disease with fewer or no side effects which are also ascribed to bolster the growth rate of the market. In addition, the market is also to grow with the increasing support from the private and public organizations on healthcare centers.

Therapeutic Vaccines Market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Regionally, North America is witnessed in leading dominant shares of the market with the rise in the flow of patients suffering from chronic diseases and others. Acceptance of advanced technology and the launch of new products in favor of the end-users are likely to outshine the demand of the therapeutic vaccines market in this region. Growing awareness over the availability of different therapies among individuals is escalating the growth of the market. Stringent rules and regulations by the government are also an attribute lavishing the growth of the market. U.S.A is the major country contributing to the highest shares for the market in North America. The increased production rate of the vaccines and also growing the development of new vaccines in research centers are major factors for the market growth in the USA. Europe is positioned next to North America in leading prominent shares of the market. Growth in the deaths of women and children due to autoimmune disease is solely to leverage the demand of the market. Also, the rising scale of healthcare centers with new techniques for chronic and fatal diseases is accelerating the demand of the market in this region.

Asia pacific is having an enormous growth rate from the past decade and is also to hit the highest CAGR in the near future. The rise in the geriatric population and growing concern towards health is elevating the growth of the market. Also, growing disposable income in urban areas is spurring the growth rate of the therapeutic vaccines market.

Leading companies operating in the Global Therapeutic Vaccines Market profiled in this report are:

Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. They have used significant revenues, global size, and deeper expertise to fund. Some of the key players influencing the global preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Disease Type                       

                                5.1.1 Autoimmune Disease Vaccines      

                                5.1.2 Cancer Vaccines   

                                                5.1.2.1 Multikine

                                                5.1.2.2 PR1 Peptide

                                                5.1.2.3 TroVax

                                                5.1.2.4 CYT004-MelQbG10

                                5.1.3 Neurological Disease Vaccines        

                                                5.1.3.1 ACC- 001

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Vaccine

                                                5.1.3.4 Alzheimer's Vaccine

                                5.1.4 Infectious Disease Vaccines             

                                                5.1.4.1 Hepatitis C Vaccines

                                                5.1.4.2 HIV/AIDS Vaccines

                                                5.1.4.3 Other Infectious Disease Vaccines

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GlaxoSMithKline plc.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Merck and Company                              

                8.3 Bavarian Nordic                        

                8.4 CSL Limited                 

                8.5 Emergent Biosolutions Inc.                  

                8.6 Novartis AG                

                8.7 Johnson and Johnson                             

                8.8 MedImmune LLC                     

                8.9 Pfizer Inc.                    

                8.10 Sanofi Pasteur                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • to provide both individuals and organizations a strong financial foothold in the marketInvestment opportunitiesExpertly devised analyst overview along with
  •  
  1. Global Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  2. Global Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  3. Global Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Global Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  5. Global Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  6. Global Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  7. Global Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  8. Global Multikine Market By Region, From 2019-2024 ( USD Billion )
  9. Global PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  10. Global TroVax Market By Region, From 2019-2024 ( USD Billion )
  11. Global CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  12. Global Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  13. Global ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  14. Global CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  15. Global Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  16. Global Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  17. Global Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  18. Global Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  19. Global HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  20. Global Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  21. North America Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  22. North America Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  23. North America Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  24. North America Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  25. North America Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  26. North America Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  27. North America Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  28. North America Multikine Market By Region, From 2019-2024 ( USD Billion )
  29. North America PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  30. North America TroVax Market By Region, From 2019-2024 ( USD Billion )
  31. North America CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  32. North America Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  33. North America ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  34. North America CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  35. North America Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  36. North America Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  37. North America Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  38. North America Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  39. North America HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  40. North America Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  41. United States Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  42. Canada Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  43. United States Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  44. Canada Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  45. United States Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  46. Canada Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  47. United States Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  48. Canada Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  49. Europe Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  50. Europe Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  51. Europe Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  52. Europe Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  53. Europe Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  54. Europe Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  55. Europe Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  56. Europe Multikine Market By Region, From 2019-2024 ( USD Billion )
  57. Europe PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  58. Europe TroVax Market By Region, From 2019-2024 ( USD Billion )
  59. Europe CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  60. Europe Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  61. Europe ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  62. Europe CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  63. Europe Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  64. Europe Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  65. Europe Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  66. Europe Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  67. Europe HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  68. Europe Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  69. U.K. Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  70. Germany Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  71. France Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  72. Italy Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  73. Spain Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  74. U.K. Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  75. Germany Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  76. France Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  77. Italy Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  78. Spain Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  79. U.K. Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  80. Germany Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  81. France Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  82. Italy Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  83. Spain Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  84. U.K. Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  85. Germany Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  86. France Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  87. Italy Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  88. Spain Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  89. Asia-Pacific Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  90. Asia-Pacific Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  91. Asia-Pacific Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  92. Asia-Pacific Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  93. Asia-Pacific Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  94. Asia-Pacific Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  95. Asia-Pacific Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  96. Asia-Pacific Multikine Market By Region, From 2019-2024 ( USD Billion )
  97. Asia-Pacific PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  98. Asia-Pacific TroVax Market By Region, From 2019-2024 ( USD Billion )
  99. Asia-Pacific CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  100. Asia-Pacific Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  101. Asia-Pacific ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  102. Asia-Pacific CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  103. Asia-Pacific Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  104. Asia-Pacific Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  105. Asia-Pacific Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  106. Asia-Pacific Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  107. Asia-Pacific HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  108. Asia-Pacific Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  109. China Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  110. India Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  111. Japan Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  112. South Korea Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  113. China Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  114. India Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  115. Japan Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  116. South Korea Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  117. China Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  118. India Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  119. Japan Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  120. South Korea Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  121. China Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  122. India Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  123. Japan Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  124. South Korea Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  125. Latin America Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  126. Latin America Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  127. Latin America Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  128. Latin America Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  129. Latin America Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  130. Latin America Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  131. Latin America Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  132. Latin America Multikine Market By Region, From 2019-2024 ( USD Billion )
  133. Latin America PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  134. Latin America TroVax Market By Region, From 2019-2024 ( USD Billion )
  135. Latin America CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  136. Latin America Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  137. Latin America ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  138. Latin America CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  139. Latin America Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  140. Latin America Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  141. Latin America Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  142. Latin America Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  143. Latin America HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  144. Latin America Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  145. Brazil Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  146. Argentina Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  147. Mexico Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  148. Brazil Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  149. Argentina Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  150. Mexico Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  151. Brazil Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  152. Argentina Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  153. Mexico Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  154. Brazil Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  155. Argentina Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  156. Mexico Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  157. Middle East & Africa Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  158. Middle East & Africa Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  159. Middle East & Africa Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  160. Middle East & Africa Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  161. Middle East & Africa Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  162. Middle East & Africa Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  163. Middle East & Africa Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  164. Middle East & Africa Multikine Market By Region, From 2019-2024 ( USD Billion )
  165. Middle East & Africa PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  166. Middle East & Africa TroVax Market By Region, From 2019-2024 ( USD Billion )
  167. Middle East & Africa CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  168. Middle East & Africa Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  169. Middle East & Africa ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  170. Middle East & Africa CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  171. Middle East & Africa Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  172. Middle East & Africa Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  173. Middle East & Africa Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  174. Middle East & Africa Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  175. Middle East & Africa HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  176. Middle East & Africa Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  177. Middle East Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  178. Africa Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  179. Middle East Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  180. Africa Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  181. Middle East Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  182. Africa Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  183. Middle East Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  184. Africa Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample